Cite
HARVARD Citation
Naimi, R. et al. (n.d.). Glepaglutide, a long-acting glucagon-like peptide-2 analog, alters postprandial intestinal hormone levels but not glucose homeostasis in patients with short bowel syndrome. Clinical nutrition. pp. S36-. [Online].